The state of Colorado currently has 2 active clinical trials seeking participants for Eczema research studies. These trials are conducted in various cities, including Denver, Aurora, Colorado Springs and Englewood.
Tofacitinib for Immune Skin Conditions in Down Syndrome
NCT04246372
Recruiting
People with Down syndrome (DS) display widespread immune dysregulation, including several immune skin conditions. This study hypothesizes that pharmacological inhibition of the increased interferon (IFN) signaling seen in DS is safe and could improve associated skin conditions. The study evaluates the safety and efficacy treatment with Tofacitinib, an FDA-approved drug known to block IFN signaling, in adolescents and adults with DS and an autoimmune and/or autoinflammatory skin condition. Inves... Read More
Gender:
All
Ages:
Between 12 years and 50 years
Trial Updated:
01/19/2024
Locations: Linda Crnic Institute for Down Syndrome, Aurora, Colorado
Conditions: Down Syndrome, Hidradenitis Suppurativa, Vitiligo, Psoriasis, Alopecia Areata, Atopic Dermatitis / Eczema
Register for Updates
Seal, Stopping Eczema and Allergy Study
NCT03742414
Recruiting
This is a randomized, controlled trial designed for children who are have already developed atopic dermatitis (AD or eczema) by 12 weeks of age. The aim is to compare the effect of proactive sequential skin care, including the twice-daily use of a tri-lipid skin barrier cream (Epiceram) or moisturizer and proactive use of fluticasone propionate cream, against reactive AD therapy, to reduce the occurrence and severity of AD in early infancy and thereby prevent food allergy (FA).
Gender:
All
Ages:
Between 1 week and 12 weeks
Trial Updated:
10/24/2023
Locations: Division of Pediatric Allergy and Clinical Immunology, National Jewish Health, Denver, Colorado
Conditions: Eczema, Infantile, Eczema, Atopic Dermatitis Eczema, Atopic Dermatitis
Register for Updates